Valeria P Lanzoni
Overview
Explore the profile of Valeria P Lanzoni including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
23
Citations
162
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Emori C, Uehara S, Carvalho-Filho R, Amaral A, de Souza E Silva I, Lanzoni V, et al.
Eur J Gastroenterol Hepatol
. 2019 Apr;
31(9):1141-1147.
PMID: 30964809
Background: The prevalence and clinical epidemiological profile of hepatitis C virus (HCV) infection have changed over time. Aim: This study aimed to evaluate these changes in renal transplant recipients (RTx)...
2.
Barros C, Haro A, Russo F, Schadock I, Almeida S, Ribeiro R, et al.
PLoS One
. 2012 Jul;
7(7):e40573.
PMID: 22829877
The Kallikrein-Kinin System (KKS) has been implicated in several aspects of metabolism, including the regulation of glucose homeostasis and adiposity. Kinins and des-Arg-kinins are the major effectors of this system...
3.
Badiani R, Becker V, Perez R, Matos C, Lemos L, Lanzoni V, et al.
World J Gastroenterol
. 2010 Aug;
16(29):3704-8.
PMID: 20677344
Aim: To evaluate the overlap of autoimmune hepatitis in hepatitis C virus (HCV)-infected patients with intense interface hepatitis. Methods: Among 1759 patients with hepatitis C submitted to liver biopsy, 92...
4.
Schiavon L, Carvalho-Filho R, Narciso-Schiavon J, Lanzoni V, Ferraz M, Silva A
Rheumatol Int
. 2010 Apr;
32(9):2917-20.
PMID: 20376663
Systemic lupus erythematosus (SLE) is a multisystemic autoimmune disease, which predominantly affects women under 50 years old. Although liver disease is not included in the diagnostic criteria, abnormal liver tests...
5.
Schiavon L, Carvalho-Filho R, Narciso-Schiavon J, Medina-Pestana J, Lanzoni V, Ferraz M, et al.
Scand J Gastroenterol
. 2010 Feb;
45(5):615-22.
PMID: 20163287
Objective: Hepatitis C is highly prevalent among kidney transplant (KT) recipients. In this population, the natural history of hepatitis C virus (HCV) infection and its proper management remains controversial. The...
6.
Becker V, Badiani R, Lemos L, Perez R, Medina-Pestana J, Lanzoni V, et al.
Eur J Gastroenterol Hepatol
. 2009 Jun;
21(12):1395-9.
PMID: 19525852
Background: Few studies have evaluated the histological aspects of hepatitis C virus (HCV) infection in hemodialysis patients and the factors related to the progression of hepatic fibrosis in this population...
7.
Schiavon L, Carvalho-Filho R, Narciso-Schiavon J, Barbosa D, Lanzoni V, Ferraz M, et al.
Hepatology
. 2008 Jun;
48(1):348-9.
PMID: 18521870
No abstract available.
8.
Carvalho-Filho R, Schiavon L, Narciso-Schiavon J, Sampaio J, Lanzoni V, Gomes Ferraz M, et al.
Liver Int
. 2008 May;
29(1):133-40.
PMID: 18507759
Background: Recent reports suggest that hepatitis C virus (HCV) carriers with serological markers of prior hepatitis B virus (HBV) infection have more advanced liver fibrosis, irrespective of HBV-DNA detection. Aims:...
9.
Carvalho-Filho R, Schiavon L, Narciso-Schiavon J, Sampaio J, Lanzoni V, Ferraz M, et al.
Liver Int
. 2008 Mar;
28(4):486-93.
PMID: 18339075
Aim: To assess the diagnostic value of modified cutoffs for aspartate aminotransferase to platelet ratio index (APRI) to predict significant liver fibrosis in human immunodeficiency virus (HIV)/hepatitis C virus (HCV)...
10.
Schiavon L, Schiavon J, Filho R, Sampaio J, Lanzoni V, Silva A, et al.
Hepatology
. 2007 Jul;
46(2):307-14.
PMID: 17634962
Unlabelled: HCV infection is common among patients with end-stage renal disease (ESRD) on hemodialysis, and it has been considered an independent risk factor for mortality in this setting. Although liver...